Clinical Trials for Celcuity

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Celcuity

Clinical Trials (6)

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

PHASE3Recruiting

674 participants

Started: Jun 30, 2025 · Completed: Dec 30, 2028

1 condition1 sponsor188 locations

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

PHASE1/PHASE2Recruiting

54 participants

Started: Jan 1, 2024 · Completed: Nov 30, 2027

6 conditions1 sponsor13 locations

Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)

PHASE3Recruiting

701 participants

Started: Dec 8, 2022 · Completed: Dec 31, 2026

1 condition1 sponsor217 locations

Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast

PHASE2Active, not recruiting

27 participants

Started: Jun 21, 2019 · Completed: Dec 15, 2024

3 conditions3 sponsors1 location

Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers

PHASE1/PHASE2Active, not recruiting

37 participants

Started: Apr 17, 2019 · Completed: Jul 31, 2024

1 condition3 sponsors5 locations

RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer

PHASE2Recruiting

180 participants

Started: Dec 24, 2018 · Completed: Aug 1, 2031

2 conditions4 sponsors3 locations